The risk of sudden cardiac death in patients with non-ST elevation acute coronary syndrome and prolonged QTc interval: effect of ranolazine | Zendy

Ewa KarwatowskaProkopczuk | Zendy; Whedy Wang | Zendy; Mei Cheng | Zendy; Dewan Zeng | Zendy; Peter J. Schwartz | Zendy; Luiz Belardinelli | Zendy

Open Access

The risk of sudden cardiac death in patients with non-ST elevation acute coronary syndrome and prolonged QTc interval: effect of ranolazine

Author(s) -

Ewa KarwatowskaProkopczuk,

Whedy Wang,

Mei Cheng,

Dewan Zeng,

Peter J. Schwartz,

Luiz Belardinelli

Publication year - 2012

Publication title -

ep europace

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.119

H-Index - 102

eISSN - 1532-2092

pISSN - 1099-5129

DOI - 10.1093/europace/eus400

Subject(s) - ranolazine , medicine , qt interval , cardiology , sudden cardiac death , long qt syndrome , acute coronary syndrome , short qt syndrome , sudden death , anesthesia , myocardial infarction

Clinical utility of QTc prolongation as a predictor for sudden cardiac death (SCD) has not been definitely established. Ranolazine causes modest QTc prolongation, yet it shows antiarrhythmic properties. We aimed to determine the association between prolonged QTc and risk of SCD, and the effect of ranolazine on this relationship.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research